ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Test Product HY07121

A development code. Also written as “Test Product HY07121 for Injection (Subcutaneous)”.

Its studies are led by Sichuan Huiyu Pharmaceutical.

Furthest: phase 2, since Oct 10, 20242 company-led studies, 2 open or runningNext primary completion: May 26, 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sichuan Huiyu Pharmaceutical22 open or runningphase 2since Oct 10, 2024Oct 10, 2024May 26, 2027phase 2 · NCT06639256

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 10, 2024First study: phase 2 study in SafetyFirst studyNCT06639256 · 258 planned · China
  2. Aug 24, 2026Phase 2 study in SafetyNCT07789327 · 254 planned
  3. Oct 13, 2026Primary completion moved from 2026-05 to 2027-05-26Date moved laterphase 2 · +12 months · NCT06639256

Ahead

  1. May 26, 2027Primary completion: phase 2 study in SafetyNCT06639256
  2. Apr 2028Primary completion: phase 2 study in SafetyNCT07789327

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07789327Safety2Not yet recruitingApr 2028254
NCT06639256Safety · China2RecruitingMay 26, 2027258

How it is read

Names in the registry

  • “Test Product HY07121 for Injection (Subcutaneous)”, 2 entries
  • “Test Product HY07121”, 1 entry

Codes read as this program: HY07121.

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.